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Abstract
Purpose: Poor physical fitness and obesity are risk factors for all cause morbidity and mortality. We aimed to clarify whether
common genetic variants of key energy intake determinants in leptin (LEP), leptin receptor (LEPR), and fat mass and obesity-
associated (FTO) are associated with aerobic and neuromuscular performance, and whether aerobic fitness can alter the
effect of these genotypes on body composition.
Methods: 846 healthy Finnish males of Caucasian origin were genotyped for FTO (rs8050136), LEP (rs7799039) and LEPR
(rs8179183 and rs1137101) single nucleotide polymorphisms (SNPs), and studied for associations with maximal oxygen
consumption, body fat percent, serum leptin levels, waist circumference and maximal force of leg extensor muscles.
Results: Genotype AA of the FTO SNP rs8050136 associated with higher BMI and greater waist circumference compared to
the genotype CC. In general linear model, no significant interaction for FTO genotype-relative VO2max (mL?kg
21?min21) or
FTO genotype-absolute VO2max (L?min
21) on BMI or waist circumference was found. Main effects of aerobic performance
on body composition traits were significant (p,0.001). Logistic regression modelling found no significant interaction
between aerobic fitness and FTO genotype. LEP SNP rs7799039, LEPR SNPs rs8179183 and rs1137101 did not associate with
any of the measured variables, and no significant interactions of LEP or LEPR genotype with aerobic fitness were observed.
In addition, none of the studied SNPs associated with aerobic or neuromuscular performance.
Conclusions: Aerobic fitness may not modify the effect of FTO variation on body composition traits. However, relative
aerobic capacity associates with lower BMI and waist circumference regardless of the FTO genotype. FTO, LEP and LEPR
genotypes unlikely associate with physical performance.
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Introduction
Obesity and low physical fitness frequently associate with each
other, and are individual risk factors for many pathological
conditions and cardiovascular mortality [1,2]. Body composition
and physical performance are outcomes of cumulative effects of
common and rare variants in a large number of genes with
environmental and gene-gene interactions [3]. The effects of
behavioural factors on human performance, including physical
activity and dietary habits have been widely studied, yet
knowledge on genetic background is sparse. The heritability
estimates for obesity range from 40% to 70% [3], from 20 to 40%
for aerobic performance [4,5], and approximately 60% for muscle
force [6]. Single nucleotide polymorphisms (SNPs) represent the
most common type of genetic variation in the human genome [7].
However, it is not known whether genetic variants in genes
encoding fat and obesity-associated (FTO), leptin (LEP), and leptin
receptor (LEPR) associate with physical performance, and whether
fitness level modifies the risk for obesity associated with these gene
variants.
Genome-wide association studies have identified the FTO gene
as the first susceptibility locus for common obesity [8,9]. Minor
allele of this variant is associated with increased risk for obesity and
elevated body weight [8,9]. In a recent meta-analysis, physical
activity level was shown to modify the relationship between the
FTO risk variant and body weight and risk of obesity [10].
However, effects of FTO genotype and its interaction with aerobic
fitness on body composition have not been reported so far. Despite
the fact that FTO is under extensive research, the role and function
of the FTO gene product remains incompletely understood.
Leptin is a peptide hormone secreted mainly from white adipose
tissue. It regulates hunger, body temperature and energy
metabolism, and has been used as a biomarker of energy
deficiency [11,12]. Recent studies have shown that obese
individuals are in fact leptin resistant [12], and that physical
exercise may restore leptin sensitivity [13]. Associations of leptin
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receptor gene (LEPR) SNP Gln223Arg (rs1137101) and leptin
(LEP) promoter region SNP -2548G/A (rs7799039) with BMI and
other body composition-related traits have been reported [14–18].
We previously demonstrated that the rs7799039 associates with
changes in body composition in response to physical training [19].
Furthermore, another LEPR SNP Lys656Asn (rs8179183) has
been reported to associate with substrate oxidation and basal
metabolic rate [20,21]. However, the interaction effects of these
SNPs with aerobic performance on body composition are not
known.
The present study investigated the association of selected SNPs
in FTO, LEP and LEPR with body composition, neuromuscular
and cardiorespiratory performance and plasma leptin levels in 846
healthy male subjects. In addition, genotype-aerobic fitness
interactions on body composition traits were studied. Our
hypothesis was that these common variants are associated with
human performance, body composition and health-related risk
factors. Furthermore, we hypothesized that aerobic fitness
modifies the relationship between the genetic variants and body
composition. The information this study provides may be used to
identify those individuals having higher health risks and tendency
for poor physical fitness, and for better understanding of the effect
of genetic factors on human physical performance.
Materials and Methods
Study Subjects
The subjects of Caucasian origin were 846 healthy male Finnish
volunteers with mean age (SD) of 2565 years. All subjects were
informed on the purpose of the study, gave a written informed
consent and underwent medical examination prior to the tests.
This study was approved by the ethics committee of the University
of Jyva¨skyla¨ and the hospital district of Central Finland.
Anthropometric data and blood samples were collected after an
overnight fast. The subjects consumed light breakfast 1 to 2 hours
before the exercise tests.
Physical Performance and Body Composition
Height, weight and waist circumference were recorded, and
body mass index (BMI, kg?m22) was calculated. Body fat and lean
mass percentage were recorded by using the eight-polar
bioimpedance method with multifrequency current (InBody 720;
Biospace Company, Seoul, Korea). Bioimpedance was recorded
after an overnight fast and with at least one day off from any
intensive physical activity.
Maximal isometric force production of the leg extensor muscles
was measured with a dynamometer (Department of Biology of
Physical Activity, University of Jyva¨skyla¨, Finland). The test was
performed in sitting position with 107-degree knee angle. The
subjects were supervised to generate maximal force as fast as
possible and maintain this force for 3 seconds. The data were
analysed with a 16-bit AD converter (CED power 1401, Cam-
bridge Electronic Design ltd, England) and Signal (2.16) software.
Aerobic fitness was assessed by maximal bicycle ergometer test
(Ergoline 800 S, Ergoselect 100 K, Ergoselect 200 K, Bitz,
Germany) as previously described [22]. The initial workload was
50 W with 25 W increase on 2-minute intervals until exhaustion.
Heart rate was monitored throughout the test (Polar T-31; Polar
Vantage, Kempele, Finland). The analyzed variables were
maximum heart rate, maximal workload and maximal oxygen
consumption (mL?kg21?min21) estimated by software (Milfit4/
Fitware, Finland) [(11.016 ? maximum work load) x (1?body
weight21) +7.0]. The test was terminated when the subject could
not maintain the required cycling speed (60–90 rpm). Physical
activity was assessed with international physical activity question-
naire (IPAQ) [23].
Blood Samples and Genotyping
The fasting blood samples were collected and analysed
immediately with a hemacytometer (Sysmex Co., Kobe, Japan).
Plasma was separated from the whole blood and stored at -80Cu
until analysis. Plasma leptin concentrations were assayed by
commercial ELISA according to the manufacturer’s instructions
(Quantikine, R&D Systems, Minneapolis, MN, USA). Assay
specifications were as follows: sensitivity limit 7.8 pg?mL21, and
maximum intra- and interassay CV% 3.3% and 5.4%, respec-
tively.
The SNP genotyping was performed using allele-specific PCR
assays. Briefly, genomic DNA was first isolated from the blood
mononuclear cells using QIAamp DNA Blood kit (Qiagen,
Hilden, Germany). Next, 50 nanograms of the DNA was
amplified with Brilliant QPCR Master Mix (Stratagene, La
Jolla, CA, USA) and allele-specific SNP assays on a Mx3000P
Real-time PCR System (Stratagene). For FTO (rs8050136) and
LEPR SNP Lys656Asn (rs8179183), the commercially available
TaqMan SNP genotyping assays were used (Applied Biosystems,
Foster City, CA, USA), and for LEP (rs7799039) and LEPR SNP
Gln223Arg (rs1137101), the following molecular beacons SNP
genotyping assays were used: LEP SNP forward primer 59-
CCTGTAATTTTCCCATGAGAAC-39 and reverse primer 59-
TGCAACATCTCAGCACTTAG-39, and the molecular bea-
cons 59-FAM/HEX-CGTGCCCGACAGGGTTGC(G/
A)CTGATCGGCACG -BHQ1; LEPR SNP forward primer
59-TCAACGACACTCTCCTTATG-39 and reverse primer 59-
TTATGGGCTGAACTGACAT-39, and the molecular beacons
59-FAM/HEX- CGGACGTGGAGTAATTTTCC(A/
G)GTCACCTCCGTCCG -BHQ1-39.
Statistics
Calculations were performed with SPSS software (Illinois,
Chicago, USA) by using one-way ANCOVA or non-parametric
tests, when appropriate. Age, smoking and earlier physical activity
were set as covariates. Smoking (smoker or non-smoker) and
physical activity (vigorous physical activity more than 3 times per
week) were set as dichotomous variables, whereas age VO2max,
BMI, waist circumference were set as continuous variables.
Genotype-VO2max interaction on BMI, waist circumference
and fat percent were analyzed by using general linear model. The
general linear model included main effects terms for earlier
physical activity, smoking, age, genotype, VO2max and genotype-
VO2max interaction. Physical activity and smoking were set as
dichotomous variables, and VO2max, age and body composition
traits were set as continuous variables. Genotype was set as discrete
variable in every analysis.
Additionally, the FTO genotype and FTO genotype-VO2max
interaction related odds for overweight (BMI over 25 kg?m22) and
abdominal obesity (waist circumference over 90 cm) were
analyzed by logistic regression. Recessive model was applied in
analysis (AA genotype vs. CA and CC genotype). Age, smoking
and physical activity were set as covariates. The subjects were
divided into quartiles according to VO2max. The 75% percentile
limits for VO2max were 3.7 L?min
21 and 46.9 mL?kg21?min21.
The subjects in the highest 25% quartile were defined as high
aerobic fitness group, and compared with the 75% percentile of
subjects (VO2max ,3.7 L?min
21 or ,46.9 mL?kg21?min21).
Data are presented as mean 6 standard deviation unless
otherwise stated. Statistical significance was set at p,0.0125 to
account for multiple testing. Bonferroni correction was applied to
FTO Genetic Variation and Aerobic Fitness
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post-hoc comparisons. Statistical power and sample sizes were
estimated with SISA web calculator [24]. A 90% level was chosen
for power calculations, and the number of subjects needed to
demonstrate 1 S.D. difference in continuous parameters was
estimated.
Results
All SNPs conformed to Hardy-Weinberg’s equilibrium. None of
the SNPs were associated with earlier physical activity estimated
with IPAQ.
In ANCOVA analysis, the FTO SNP rs8050136 associated
with BMI and waist circumference (Table 1). Genotype AA
carriers had significantly higher BMI and greater waist
circumference compared to the genotype CC carriers. In
general linear model, the main effects of relative and absolute
VO2max on BMI and waist circumference were significant
(p,0.001). However, no significant FTO genotype-relative
VO2max (mL?kg
21?min21) interaction on BMI (p= 0.081) or
waist circumference (p = 0.093) was found. In addition, the test
result was insignificant when FTO genotype-absolute VO2max
(L?min21) interaction on BMI (p= 0.937) or waist circumference
(p = 0.262) were analyzed (Figures 1–4). In logistic regression,
genotype AA increased odds for waist circumference over
90 cm. However, the interaction of genotype AA with high
VO2max was insignificant (Table 2). No association was found
with aerobic fitness (VO2max expressed as L?min
21 or
mL?kg21?min21) (Table 1).
In ANCOVA analysis, LEP SNP rs7799039 did not associate
with any variable (Table 3). No interactions were observed
between aerobic fitness and genotype. LEPR SNP rs1137101 did
not associate with BMI, body fat, leptin levels or physical
performance in ANCOVA (Table 3), and no aerobic perfor-
mance-genotype interactions were observed in the general linear
model. In ANCOVA analysis, LEPR Lys656Asn SNP rs8179183
Figure 1. Linear regression analysis. The main effect of VO2max (mL?kg
21?min21) on BMI was significant (p,0.001). The main effects of FTO
genotype and FTO genotype-VO2max (mL?kg
21?min21) interaction were not significant (p = 0.029 and p=0.081, respectively).
doi:10.1371/journal.pone.0051635.g001
Table 1. Showing the results of ANCOVA–analysis according
to FTO genotype.
FTO SNP rs8050136 (N=773)
Genotype CC CA AA
N= 269 N=380 N= 124
35% 49% 16%
BMI (kg? m22) 24.563.6 24.863.7 25.764.3*
Waist circumference (cm) 85.8610.3 86.069.7 88.8612.2#
Fat per cent (%) 17.567.2 17.967.0 19.468.0
VO2max (mL?kg21?min21) 42.068.3 41.867.8 40.268.6
VO2max (L?min21) 3.2960.56 3.3060.58 3.3060.62
Maximal working capacity
(Watts)
244.2644.7 245.0646.5 242.7649.1
Maximal force of leg
extensors (N)
29276872 29506816 29426992
Plasma leptin (pg?mL21) 359863657 370263780 428964278
Earlier physical activity, smoking and age were set as covariates. Bonferroni
correction was accounted for multiple post-hoc comparisons.
BMI: p = 0.007 for main effect, *p = 0.005 between the genotype groups CC and
AA.
Waist circumference: p = 0.012 for main effect, #p= 0.012 between the
genotype groups CC and AA.
p.0.0125 for main effect between genotype groups for rest of the variables.
doi:10.1371/journal.pone.0051635.t001
FTO Genetic Variation and Aerobic Fitness
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did not associate with any variable (Table 3). In addition, no
interactions were observed between genotype and aerobic fitness
in the general linear model.
Discussion
The main finding of the present study was that aerobic fitness
does not modify the effect of FTO variation on BMI or waist
circumference. However, relative aerobic capacity did associate
Figure 2. Linear regression analysis. The main effect of VO2max (L?min
21) on BMI was significant (p,0.001). The main effects of FTO genotype
and FTO genotype-VO2max (L?min
21) interaction were not significant (p = 0.964 and p=0.937, respectively).
doi:10.1371/journal.pone.0051635.g002
Table 2. Showing results of the logistic regression analysis.
OR 95% C.I. p-value
BMI over 25 kg?m22 adjusted for age, smoking, physical activity and relative aerobic fitness (mL?kg21?min21)
Genotype AA 1.51 0.96–2.37 0.073
VO2max (.46.9 mL?kg
21?min21) 0.15 0.09–0.25 ,0.001
Genotype AA by VO2max (.46.9 mL?kg
21?min21) 1.31 0.43–3.96 0.639
BMI over 25 kg?m22 adjusted for age, smoking, physical activity and absolute aerobic fitness (L?min21)
Genotype AA 1.61 1.02–2.53 0.038
VO2max (.3.7 L?min
21) 1.10 0.75–1.63 0.626
Genotype AA by VO2max (.3.7 L?min
21) 1.02 0.41–2.58 0.959
Waist circumference over 90 cm adjusted for age, smoking, physical activity and relative aerobic fitness (mL?kg21?min21)
Genotype AA 1.92 1.22–3.03 0.005
VO2max (.46.9 mL?kg
21?min21) 0.08 0.04–0.18 ,0.001
Genotype AA by VO2max (.46.9 mL?kg
21?min21) 1.07 0.19–5.94 0.941
Waist circumference over 90 cm adjusted for age, smoking, physical activity and absolute aerobic fitness (L?min21)
Genotype AA 1.96 1.22–3.15 0.005
VO2max (.3.7 L?min
21) 1.26 0.81–1.97 0.299
Genotype AA by VO2max (.3.7 L?min
21) 0.88 0.33–2.40 0.884
OR and 95% C.I. for the genotype AA (vs. genotype CA and CC) of the FTO rs8050136 according to overweight and abdominal obesity.
doi:10.1371/journal.pone.0051635.t002
FTO Genetic Variation and Aerobic Fitness
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Figure 3. Linear regression analysis. The main effect of VO2max (mL?kg
21?min21) on waist circumference was significant (p,0.001). The main
effects of FTO genotype and FTO genotype-VO2max (mL?kg
21?min21) interaction were not significant (p = 0.040 and p=0.093, respectively).
doi:10.1371/journal.pone.0051635.g003
Figure 4. Linear regression analysis. The main effect of VO2max (L?min
21) on waist circumference was significant (p,0.001). The main effects of
FTO genotype and FTO genotype-VO2max (L?min
21) interaction were not significant (p = 0.521 and p= 0.262, respectively).
doi:10.1371/journal.pone.0051635.g004
FTO Genetic Variation and Aerobic Fitness
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with lower BMI and waist circumference regardless of the FTO
genotype. We also report that the LEP promoter -2548 SNP and
the LEPR Lys656Asn SNP did not associate with BMI, waist
circumference or body fat percent.
Our observations that genotype AA of the FTO variant
associated with higher BMI and greater waist circumference are
in line with a recent meta-analysis [25]. Our novel finding,
however, is that aerobic fitness does not modify the effect of FTO
variation on BMI and waist circumference. In another recent
meta-analysis, the level of physical activity was shown to modify
the relationship between the FTO risk variant and body weight
and risk of obesity [10]. Nevertheless, these studies are not fully
comparable to ours because at present, this is the first study to
report objectively measured aerobic fitness - FTO-interaction. The
questionnaire-based assessment of physical activity may have some
reporting bias [26]. In addition, the present findings may be
explained by the fact that apart from physical activity, other
factors may affect aerobic fitness. Approximately 20 to 40% of
VO2max has been estimated to be heritable, and other factors,
such as physical activity, intake of carbohydrates, smoking, body
weight, blood haemoglobin levels, age and presence of chronic
disease account for the remaining [4,5]. In addition, the present
and earlier studies differ in study design because in our study, all
subjects were young males. Nevertheless, in the present study,
aerobic fitness was associated with body composition traits
regardless of the FTO genotype. Despite lack of FTO genotype-
aerobic fitness interaction, the genotype AA carriers are more
susceptible to obesity and may benefit from increased aerobic
fitness to a greater extent due to its favourable effects on the
regulation of body weight. In the present study, FTO variant was
not found to associate with aerobic fitness, which is in line with
previous studies [27,28]. It can be speculated that low physical
fitness combined with increased body weight in the allele A
carriers of the FTO variant may further increase risk for lifestyle-
associated disease, such as cardiovascular events [29]. This would
in turn highlight the importance of physical activity to attenuate
risk for obesity. Furthermore, the studied FTO variant did not
associate with plasma leptin levels, which in line with other studies
[30,31].
In the present study, the leptin promoter SNP rs7799039 did not
associate with BMI, which is supported by earlier reports [17,18].
It has been speculated that lower leptin levels in allele G carriers of
this SNP would be an underlying mechanism for increased
accumulation of adipose tissue [32]. However, in the present
study, leptin levels were similar between the genotype groups.
Furthermore, no association with aerobic fitness, neuromuscular
performance, or interaction with VO2max was found.
The LEPR Gln223Arg genotype showed no association with
cardio-respiratory fitness, which is supported by our previous
report [19]. Furthermore, in agreement with other studies [19,33],
no differences in leptin levels between the genotype groups were
found, although controversial findings does exist [15,34,35]. It
should be noted, however, that in many published studies,
interpretation of the results is limited due to small sample size,
differences in ethnicity of the subjects, and other factors related to
the study settings.
The LEPR Lys656Asn SNP did not associate with BMI, waist
circumference or body fat per cent, and these findings are also
supported by others [36–38]. Moreover, subjects of the present
study were not morbidly obese, and small prevalence of the minor
Asn allele may also complicate evaluation of the effect of this SNP
on body weight and body composition. Furthermore, no
significant genotype-VO2max interactions were found.
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There are certain limitations to the present study. First, the
sample size was moderate for genetic association analyses. The
relatively large confidence intervals may bias identification of a
true interaction in logistic regression analysis. In addition, all
subjects were males, which may affect generalization of the results
to other populations. Our study design was cross-sectional, which
may increase risk for selection bias. However, earlier physical
activity status was assessed with IPAQ survey, and no associations
with pre-study physical activity and genotypes were found. The
bioimpedance method is both sensitive and specific for analysis of
body fat mass, but may have limitations for accurate evaluation of
muscle mass [39]. The method for assessing aerobic fitness was
indirect, whereas direct gas exchange analysis would provide
greater accuracy.
In conclusion, aerobic fitness may not modify the effect of FTO
variation on body composition traits. However, relative aerobic
capacity had a favourable effect on BMI and waist circumference,
regardless of the FTO genotype. It is unlikely that FTO, LEP and
LEPR genotypes associate with physical performance. These
findings can be applied in sports medicine to decrease risk for
diseases related to sedentary lifestyle and obesity, where improved
aerobic fitness is beneficial regardless of the FTO-related
predisposition to obesity.
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